Substituted 6,6-hetero-bicyclic derivatives

摘要

This invention relates to compounds of formula (I), wherein A, B, D, E, K, G, R<3> and R<5> are defined as in the specification, and to the pharmaceutically acceptable salts of such compounds. Compounds (I) are corticotropin releasing factor (hormone) CRF (CRH) antagonists.